Pfizer Inc. (NYSE: PFE) beats Q3-FY2026 EPS consensus of $0.73 per share — earnings report November 3, 2026 before market open (confirmed by Pfizer Investor Relations or Bloomberg by November 3, 2026, 12:00 PM ET)
Pending
✦ AI-generated prediction
Published on 28. October 2026
·
Predicted for 3. November 2026
·
Based on: Historical Cycle
Analysts expect $0.73 adjusted EPS for Q3 2026, ~17% below the prior year's $0.87. The decline primarily reflects a one-time ~$650M charge from the Innovent deal (~$0.10/share), already factored into consensus. Pfizer has consistently beaten consensus estimates in each of the last four quarters. The FY2026 guidance of $2.80–$3.00 EPS and structural turnaround (stock +21% YTD in 2026, forward P/E rising from ~9x to ~11x) support another beat. No specific Polymarket/Kalshi market available — probability calibrated on historical beat rate.
Data basis for this prediction
- MarketBeat: Pfizer Q3 FY2026 EPS-Konsens $0,7280, Umsatz-Konsens $15,86 Mrd. (28.10.2026)
- TIKR/Yahoo Finance: Pfizer +21 % in 2026, Forward-P/E-Anstieg ~9× auf ~11× (28.10.2026)
- Pfizer FY2026 Guidance $2,80–$3,00 EPS (Unternehmensaussage, Okt. 2026)
- MarketBeat: Pfizer beat EPS-Konsens in den letzten 4 aufeinanderfolgenden Quartalen (Stand 28.10.2026)
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
📈 Economy
✦ AI
Gold (XAU/USD) rose to $4,134.83 on 5 November 2026 — driven by the Democratic midterm sweep (higher fiscal spending expected) and persistent inflation pressure. Kalshi's Dec 31 settlement market shows ~32% probability for a close above $4,400 and ~43% for above $4,300. Reaching the $4,400 year-end target would require a further ~6.4% gain. Supporting factors: fiscal expansion, geopolitical risks, structurally high central bank demand; UBS forecasts $4,800, JPMorgan $6,000 at year-end. Headwind: hawkish Fed stance (Polymarket: 72.5% for a December rate hike to 4.00–4.25%). Prediction anchors on Kalshi's ~32% for >$4,400.
📈 Economy
✦ AI
Gold traded at approximately $4,130 per troy ounce on November 5, 2026 — a one-day gain of +1.68% (+$66) following the Democratic midterm sweep (Democrats won both the Senate and the House, per AP/NBC, November 5, 2026). Polymarket prices a 49% probability of gold exceeding $4,200 in November (as of November 5, 2026). The target is only 1.7% above today's closing level with 25 trading days remaining. Upside drivers: Iran de-escalation by new Democratic Congress, falling oil prices (WTI −1.13% to $87.13). Risk factors: profit-taking, rising real yields.
📈 Economy
✦ AI
Cisco has beaten Non-GAAP EPS consensus in 7 of its last 8 quarters. For Q1 FY2027 (August–October 2026) the company itself guided $1.32–$1.34 per share — the market consensus of $1.32 sits at the bottom of this self-guided range, which historically signals a beat for Cisco (Q4 FY2026: $1.22 vs. consensus $1.17). AI-networking growth, Splunk integration synergies, and record Q4 FY2026 revenue ($17.25B) confirm the structural growth momentum. Q1 FY2027 revenue consensus: $18.11B (within guidance range $18.0–18.2B).